Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Non-Oncologic Total Femoral Arthroplasty: Retrospective Review JOURNAL OF ARTHROPLASTY Amanatullah, D. F., Trousdale, R. T., Hanssen, A. D., Lewallen, D. G., Taunton, M. J. 2014; 29 (10): 2013-2015

Abstract

Total femoral arthroplasty (TFA) is an option to amputation in the setting of excessive bones loss during revision total hip and knee arthroplasty. Twenty non-oncologic TFAs with a minimum of 2years follow-up were retrospectively reviewed. The average clinical follow-up was 73±49months. The incidence of new infection was 25% (5/20), while the overall infection rate was 35% (7/20). The incidence of primary hip instability was 10% (2/20), while the overall instability rate was 25% (5/20). Six patients (30%) required revision. The average pre-operative HHS was 30.2±13.1. The average post-operative HHS was 65.3±16.9. TFA is a viable alternative to amputation in non-oncologic patients with massive femoral bone deficiency. However, TFA performed poorly in the setting of infection and instability.

View details for DOI 10.1016/j.arth.2014.05.012

View details for Web of Science ID 000343159700024

View details for PubMedID 25041874